Regenerative Medical Technology Group Inc.
RMTG
$0.09
$0.00-4.44%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 94.33% | 36.96% | 24.17% | 56.87% | 68.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 94.33% | 36.96% | 24.17% | 56.87% | 68.65% |
| Cost of Revenue | 138.61% | 88.25% | 78.28% | 117.01% | 78.08% |
| Gross Profit | 72.74% | 13.60% | -0.45% | 32.20% | 64.40% |
| SG&A Expenses | 86.07% | 49.97% | 34.33% | 28.27% | 31.10% |
| Depreciation & Amortization | 116.53% | 66.96% | 27.38% | -55.14% | -52.82% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 105.67% | 63.69% | 48.14% | 43.33% | 34.71% |
| Operating Income | -60.64% | -291.58% | -689.81% | 70.42% | 169.16% |
| Income Before Tax | -155.53% | -84.93% | -42.91% | -38.89% | 63.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -155.53% | -84.93% | -42.91% | -38.89% | 63.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -155.53% | -84.93% | -42.91% | -38.89% | 63.26% |
| EBIT | -60.64% | -291.58% | -689.81% | 70.42% | 169.16% |
| EBITDA | -15.16% | -154.71% | -215.88% | 436.12% | 572.22% |
| EPS Basic | -149.29% | -82.73% | -41.76% | -38.40% | 63.49% |
| Normalized Basic EPS | -138.14% | -73.28% | -34.39% | -0.96% | 50.77% |
| EPS Diluted | -149.29% | -82.73% | -41.76% | -38.40% | 63.49% |
| Normalized Diluted EPS | -138.14% | -73.28% | -34.39% | -0.96% | 50.77% |
| Average Basic Shares Outstanding | 3.32% | 2.05% | 0.94% | 0.35% | 0.54% |
| Average Diluted Shares Outstanding | 3.32% | 2.05% | 0.94% | 0.35% | 0.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |